All Cosmos Bio-Tech Holding Corporation reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was TWD 523.55 million compared to TWD 777.97 million a year ago. Net income was TWD 28.49 million compared to TWD 40.33 million a year ago.

Basic earnings per share from continuing operations was TWD 0.44 compared to TWD 0.63 a year ago. Diluted earnings per share from continuing operations was TWD 0.34 compared to TWD 0.63 a year ago.